Intraoperative Radiation Therapy: A Large Integrated Health Care System’s Approach and Outcomes
The Permanente Journal · 2023
DOI: 10.7812/tpp/22.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Permanente Journal, 2023. Verfasst von Annie Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California San Francisco, Oakland, CA, USA. Hauptthemen laut MEDLINE: Delivery of Health Care, Integrated, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Intraoperative radiation therapy (IORT) may not be as effective in the community compared with clinical trials.
Methods
The authors reviewed data from the electronic health records of patients who received IORT between February 2014 and February 2020 at a single center within a large integrated health care system. The primary outcome was ipsilateral breast tumor recurrence.
Results
Of 5731 potentially eligible patients, 245 (4.3%) underwent IORT (mean age: 65.4 ± 0.4 years; median follow-up time: 3.5 years ± 2.2 months). According to the American Society for Radiation Oncology's accelerated partial breast irradiation guidelines based on final pathology, 51% of patients were suitable candidates for IORT, 38.4% were cautionary, and 10.6% were unsuitable. For adjuvant therapy, 6.5% had consolidative whole breast irradiation, and 66.4% received endocrine treatment. At the median follow-up time of 3.5 years, overall ipsilateral breast tumor recurrence was 3.7%. Recurrences tended to be more frequent in patients who refused or did not complete endocrine treatment than in those who received it (7.4% vs 1.9%, p = 0.07). The complication rate was 14.7%, with seroma being the most common (8.2%).
Discussion
The IORT ipsilateral breast tumor recurrence rate of 3.7% confirms a higher-than-expected rate compared to randomized clinical trials, possibly due to less compliance with endocrine therapy.
Conclusion
The authors subsequently revised their IORT protocol to require endocrine treatment as a part of the IORT treatment plan and to strongly recommend adjuvant whole breast irradiation for all patients deemed cautionary or unsuitable for IORT according to the American Society for Radiation Oncology's accelerated partial breast irradiation guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of California San Francisco, Oakland, CA, USA.
- Department of Radiation Oncology, Kaiser Permanente Northern California, Oakland, CA, USA.
- Department of Surgery, Kaiser Permanente Northern California, Oakland, CA, USA.
- The Kaiser Permanente Northern California Division of Research, Oakland, CA, USA.
- Department of Medical Oncology, Kaiser Permanente Northern California, Oakland, CA, USA.
ORCID-Profile: Annie Tang, Jessica M Dzubnar
Zitieren
APA
Tang, A., Dzubnar, J. M., Kelly, J. F., Banks, K. C., Phillips, J. L., Cureton, E. A., Svahn, J. D., Mai, V., Lyon, L. L., Thomas, E. S., & Shim, V. C. (2023). Intraoperative Radiation Therapy: A Large Integrated Health Care System’s Approach and Outcomes. The Permanente Journal. https://doi.org/10.7812/tpp/22.122
Vancouver
Tang A, Dzubnar JM, Kelly JF, Banks KC, Phillips JL, Cureton EA, et al. Intraoperative Radiation Therapy: A Large Integrated Health Care System’s Approach and Outcomes. The Permanente Journal. 2023. doi:10.7812/tpp/22.122
BibTeX
@article{Tang2023,
author = {Tang, Annie and Dzubnar, Jessica M and Kelly, Jason F and Banks, Kian C and Phillips, Jacquelyn L and Cureton, Elizabeth A and Svahn, Jonathan D and Mai, Valerie and Lyon, Liisa L and Thomas, Eva S and Shim, Veronica C},
title = {Intraoperative Radiation Therapy: A Large Integrated Health Care System’s Approach and Outcomes},
journal = {The Permanente Journal},
year = {2023},
doi = {10.7812/tpp/22.122}
}
EUVIMED